Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 67-73, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skeie, S.
Right arrow Articles by Sandberg, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skeie, S.
Right arrow Articles by Sandberg, S.
Related Collections
Right arrow Laboratory Management
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:67-73.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Patient-derived Quality Specifications for Instruments Used in Self-Monitoring of Blood Glucose

Svein Skeiea,1, Geir Thue1 and Sverre Sandberg1

1 NOKLUS, Norwegian Center for External Quality Improvement of Primary Care Laboratories, Division of General Practice, Ulriksdal 8c, University of Bergen, N-5009 Bergen, Norway.
a Address correspondence to this author at: Department of Medicine, Rogaland Central Hospital, PO Box 8100, 4068 Stavanger, Norway. svskeie{at}online.no.

Background: Instruments for self-monitoring of glucose (SMBG) are increasingly used by diabetic patients. Information is limited on how patients use and interpret SMBG results, and no quality specifications for such instruments are based on the opinions of patients.

Methods: Type 1 diabetic patients (n = 201) filled in a questionnaire eliciting daily limits for blood glucose (BG) and changes of BG considered significant at different glucose concentrations. From these responses, patient-derived quality specifications were calculated in different clinical situations with low, intermediate, and high BG concentrations.

Results: Mean age of the patients was 31.8 years, mean diabetes duration was 14.7 years, and mean SMBG duration was 10.0 years with a mean frequency of 11.2 measurements/week. The threshold for hypoglycemic symptoms was 3.0 mmol/L (54 mg/dL), and the mean daily BG target window was 4.3–10.4 mmol/L (77–187 mg/dL). The mean absolute BG changes producing actions from the patients ranged from 1.1 mmol/L (20 mg/dL) to 3.6 mmol/L (65 mg/dL). The analytical quality specifications for imprecision depended on the clinical situation. Excluding the hypoglycemic situation, the analytical CV needed to fulfill the expectations of 75% of the patients was 6.4–9.7%. The analytical quality specification for CV at hypoglycemic concentrations was 3.1%.

Conclusions: Instruments for self-measurements of glucose with an imprecision (CV) of <=5% and bias <=5% meet the expectations of >75% of patients in clinical situations other than hypoglycemia.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
G. B.B. Kristensen, K. Nerhus, G. Thue, and S. Sandberg
Results and Feasibility of an External Quality Assessment Scheme for Self-Monitoring of Blood Glucose
Clin. Chem., July 1, 2006; 52(7): 1311 - 1317.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. B.B. Kristensen, N. G. Christensen, G. Thue, and S. Sandberg
Between-Lot Variation in External Quality Assessment of Glucose: Clinical Importance and Effect on Participant Performance Evaluation
Clin. Chem., September 1, 2005; 51(9): 1632 - 1636.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Skeie, C. Perich, C. Ricos, A. Araczki, A. R. Horvath, W. P. Oosterhuis, T. Bubner, G. Nordin, R. Delport, G. Thue, et al.
Postanalytical External Quality Assessment of Blood Glucose and Hemoglobin A1c: An International Survey
Clin. Chem., July 1, 2005; 51(7): 1145 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. E. Winter
A Rosetta Stone for Insulin Treatment: Self-Monitoring of Blood Glucose
Clin. Chem., June 1, 2004; 50(6): 985 - 987.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
G. B.B. Kristensen, K. Nerhus, G. Thue, and S. Sandberg
Standardized Evaluation of Instruments for Self-Monitoring of Blood Glucose by Patients and a Technologist
Clin. Chem., June 1, 2004; 50(6): 1068 - 1071.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Skeie, G. Thue, K. Nerhus, and S. Sandberg
Instruments for Self-Monitoring of Blood Glucose: Comparisons of Testing Quality Achieved by Patients and a Technician
Clin. Chem., July 1, 2002; 48(7): 994 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Clin. Chem., March 1, 2002; 48(3): 436 - 472.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Skeie, G. Thue, and S. Sandberg
Interpretation of Hemoglobin A1c (HbA1c) Values among Diabetic Patients: Implications for Quality Specifications for HbA1c
Clin. Chem., July 1, 2001; 47(7): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Geffken and W. E. Winter
Hardware and Software in Diabetes Mellitus: Performance Characteristics of Hand-held Glucose Testing Devices and the Application of Glycemic Testing to Patients' Daily Diabetes Management
Clin. Chem., January 1, 2001; 47(1): 11 - 12.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.